Ohio State Navbar

Sign In

Ohio State Researchers Restore Immune Function In Spinal Injured Mice

Share this news item:

Contact Us

For Media Inquiries:
614-293-3737

To find a doctor
or get a referral:
614-293-5123
or 800-293-5123

To inquire about participating in a clinical trial at Ohio State:
614-293-HERO (4376)

Posted: 8/6/2013

<p>Phillip Popovich, PhD</p>

Phillip Popovich, PhD

COLUMBUS, Ohio – In a new study, researchers at The Center for Brain and Spinal Cord Repair at The Ohio State University Wexner Medical Center show that is possible to restore immune function in spinal injured mice.

People with spinal cord injury often are immune compromised, which makes them more susceptible to infections. Why these people become immune-suppressed is not known, but the Ohio State study found that a disorder called autonomic dysreflexia can cause immune suppression.

Autonomic dysreflexia is a potentially dangerous complication of high-level spinal cord injury characterized by exaggerated activation of spinal autonomic (sympathetic) reflexes. This can cause an abrupt onset of excessively high blood pressure that can cause pulmonary embolism, stroke and in severe cases, death.

“Our research offers an explanation for why people with spinal cord injuries develop a condition referred to as ‘central immune depression syndrome.’ Their immune systems, which are required to fight off infection, are suppressed due to damage or malfunction in regions of the spinal cord that help control immune function,” said principal investigator Phillip G. Popovich, Ph.D., Professor of Neuroscience in Ohio State’s College of Medicine and Director of Ohio State’s Center for Brain and Spinal Cord Repair.

The study is published in The Journal of Neuroscience.

Researchers found that autonomic dysreflexia develops spontaneously in spinal cord injured mice, and becomes more frequent as time passes from the initial spinal cord injury.

They also found that simple, everyday occurrences that activate normal spinal autonomic reflexes, such as having bowel movements or emptying the bladder, become hyperactive and suppress immune function in people with spinal cord injury.

In the study, Popovich and colleagues were able to restore immune function in mice with spinal cord injuries using drugs that inhibit norepinephrine and glucocorticoids, immune modulatory hormones that are produced during the onset and progression of AD. They also observed in a patient with a high-level spinal cord injury that briefly inducing autonomic dysreflexia impaired immune function, confirming that their findings in mice have relevance to humans.

“Although we don't know how to fix this yet, we also show that it is possible to restore immune function in spinal injured mice,” Popovich said. “After spinal cord injury, the ability of the spinal cord to control the immune system is impaired. As result, these individuals become susceptible to infection, and often die from these infections. For those that survive, the infections can impair what little function they have left after the spinal cord injury.”

The study found that autonomic dysreflexia causes immune suppression in part by releasing into blood and immune organs high levels of immune modulatory hormones that non-selectively kill mature and immature white blood cells in the spleen, said first author Yi Zhang, a post-doctoral neuroscience researcher at Ohio State.

“Our research is laying the groundwork for potential therapeutic targets for reversing central immune depression syndrome,” Zhang said, adding that further research is needed.

Ohio State’s Center for Brain and Spinal Cord Repair is an interdisciplinary collaboration of basic and clinical scientists working to promote recovery and repair and to discover new treatments for individuals who suffer from brain or spinal cord injuries.

Ohio State researchers involved in this study are Zhen Guan, Brenda Reader, Todd Shawler, Shweta Mandrekar-Colucci, Kun Huang, Zachary Weil, Anna Bratasz, Jonathan Wells, Nicole Powell, John Sheridan and Caroline Whitacre. Other researchers involved in this study include Alexander Rabchevsky, University of Kentucky and Mark Nash, University of Miami Miller School of Medicine.

This research was supported by the National Institutes of Health (R21 NS067260) and the Ray W. Poppleton Endowment.

# # #

Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu

 

 

College of Medicine; Research; OSU College of Medicine; OSU Medical Center; Basic Research; Research Findings; Researchers